Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy

Yun Mi Choi, Mi Kyung Kwak, Sang Mo Hong, Eun-Gyoung Hong

Endocrinol Metab. 2019;34(3):268-274. Published online September 26, 2019
DOI: https://doi.org/10.3803/EnM.2019.34.3.268

Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy

Yun Mi Choi, Mi Kyung Kwak, Sang Mo Hong, Eun-Gyoung Hong

Endocrinology and Metabolism. 2019;34(3):268

Link1 Link2 Link3

Predicting the Risk of Graves Disease Relapse: Commentary on “Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease”

D. Gallo, M.L. Tanda, E. Piantanida

Endocrine Practice. 2020;26(9):1039-1041

Link1 Link2

Thyroid Peroxidase Antibody Positivity is Associated With Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease

Christopher A. Muir, Graham R.D. Jones, Jerry R. Greenfield, Andrew Weissberger, Katherine Samaras

Endocrine Practice. 2020;26(9):1026-1030

Link1 Link2

Differences Between Changes in Serum Thyrotropin-Binding Inhibitory Antibodies and Thyroid-Stimulating Antibodies in the Course of Antithyroid Drug Therapy for Graves' Disease

YURIKO YAMANO, JUNTA TAKAMATSU, SADAKI SAKANE, KEISUKE HIRAI, KANJI KUMA, NAKAAKI OHSAWA

Thyroid. 1999;9(8):769-773

Link1

Genotype and Phenotype Predictors of Relapse of Graves’ Disease after Antithyroid Drug Withdrawal

Pei-Wen Wang, I-Ya Chen, Suh-Hang Hank Juo, Edward Hsi, Rue-Tsuan Liu, Ching-Jung Hsieh

European Thyroid Journal. 2012;1(4):251-258

Link1 Link2

Sensitive Thyrotropin and Thyrotropin-Receptor Antibody Determinations One Month After Discontinuation of Antithyroid Drug Treatment as Predictors of Relapse in Graves' Disease

Beate Quadbeck, Rudolf Hoermann, Ulla Roggenbuck, Susanne Hahn, Klaus Mann, Onno E. Janssen

Thyroid. 2005;15(9):1047-1054

Link1

Valuable predictive features of relapse of Graves’ disease after antithyroid drug treatment

Xingjun Liu, Bingyin Shi, Hao Li

Annales d'Endocrinologie. 2015;76(6):679-683

Link1 Link2

Relapse of Graves' Disease After Successful Outcome of Antithyroid Drug Therapy: Results of a Prospective Randomized Study on the Use of Levothyroxine

Rudolf Hoermann, Beate Quadbeck, Ulla Roggenbuck, István Szabolcs, Johannes Pfeilschifter, Wieland Meng, Kirsten Reschke, Klaus Hackenberg, Juergen Dettmann, Brigitte Prehn, Herbert Hirche, Klaus Mann

Thyroid. 2002;12(12):1119-1128

Link1

A Polymorphism of Interferon-γ Gene Associated with Changes of Anti-Thyrotropin Receptor Antibodies Induced by Antithyroid Drug Treatment for Graves' Disease in Japanese Patients

Tomoka Fukutani, Yuji Hiromatsu, Hiroo Kaku, Ikuyo Miyake, Tokunori Mukai, Yoichi Imamura, Shusuke Kohno, Naoko Takane, Shingo Shoji, Shuichi Otabe, Kentaro Yamada

Thyroid. 2004;14(2):93-97

Link1

THYROID ANTIBODIES AND THYROGLOBULIN-LIKE PRODUCTS IN SERUM DURING ANTITHYROID THERAPY

T. Hjort, U. Birk Lauridsen, I. Persson

Acta Medica Scandinavica. 2009;188(1-6):431-437

Link1 Link2